Stock Earnings

Question 1

Xenon Pharmaceuticals Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Xenon Pharmaceuticals Inc 的总资产为 $798，净loss为 $-234

Question 2

XENE 的关键财务比率是什么？

Accepted Answer

Xenon Pharmaceuticals Inc 的流动比率是 18.55，净利 margin 为 0，每股销售为 $0。

Question 3

Xenon Pharmaceuticals Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Currently Xenon Pharmaceuticals Inc data is not available.

Question 4

Xenon Pharmaceuticals Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Xenon Pharmaceuticals Inc 的净loss为 $-234

Question 5

Xenon Pharmaceuticals Inc 有负债吗？

Accepted Answer

yes，Xenon Pharmaceuticals Inc 的负债为 43

Question 6

Xenon Pharmaceuticals Inc 的流通股有多少？

Accepted Answer

Xenon Pharmaceuticals Inc 的总流通股为 76.41

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	7	0	0	9	18	32
Revenue Growth (YoY)	--	--	-100%	-50%	-44%	433%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	72	68	46	32	21	12
Research & Development	252	210	167	105	75	50
Operating Expenses	325	279	214	138	97	63
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-282	-238	-182	-125	-78	-29
Income Tax Expense	-4	-4	0	0	0	0
Net Income	-278	-234	-182	-124	-77	-28
Net Income Growth	40%	28.99%	47%	61%	175%	-30%
Shares Outstanding (Diluted)	78.95	77.89	66.88	60.54	43.63	34.54
Shares Change (YoY)	2%	16%	10%	39%	26%	33%
EPS (Diluted)	-3.54	-3	-2.72	-2.06	-1.77	-0.81
EPS Growth	38%	10%	32%	16%	119%	-47%
Free Cash Flow	-232	-184	-156	-101	-71	-50
Free Cash Flow Per Share	-2.93	-2.36	-2.33	-1.66	-1.62	-1.44
Gross Margin	--	--	--	--	--	--
Operating Margin	-4,542.85%	0%	0%	-1,433.33%	-433.33%	-96.87%
Profit Margin	-3,971.42%	0%	0%	-1,377.77%	-427.77%	-87.5%
Free Cash Flow Margin	-3,314.28%	0%	0%	-1,122.22%	-394.44%	-156.25%
EBITDA	-316	-277	-212	-128	-78	-31
EBITDA Margin	-4,514.28%	0%	0%	-1,422.22%	-433.33%	-96.87%
D&A For EBITDA	2	2	2	1	0	0
EBIT	-318	-279	-214	-129	-78	-31
EBIT Margin	-4,542.85%	0%	0%	-1,433.33%	-433.33%	-96.87%
Effective Tax Rate	1.41%	1.68%	0%	0%	0%	0%

Xenon Pharmaceuticals Inc (XENE) Price